Anti-Müllerian Hormone

Anti-Müllerian Hormone, commonly abbreviated AMH, is a biomarker classified among the sex hormones. It is measured in laboratory testing, where results describe the amount of this hormone detected in a sample.

Anti-Müllerian Hormone is measured from a serum sample. When arranging the test, confirm that the laboratory is measuring Anti-Müllerian Hormone in serum and that the result will be reported using the laboratory’s stated units and reference interval.

Fasting is not required for this measurement, so the test does not require a fasting collection. No meal restriction is specified as part of the collection conditions. The result can be read against the general reference range and the sex-specific ranges shown with the report; the applicable comparison depends on the person being tested and the laboratory’s reporting context.

The result may also be considered alongside related markers such as Fsh and Estradiol when a clinician is assessing the broader hormonal picture. These measurements provide context rather than replacing interpretation of the Anti-Müllerian Hormone result itself. Anyone arranging testing for a medical concern can discuss the appropriate test and interpretation with a clinician.

Anti-Müllerian Hormone results should be read against the reference range printed on the same laboratory report. A reference range is the broader interval used to identify results that may need further interpretation, while an optimal range is a narrower interval used for a more specific comparison. These ranges are not interchangeable, and a result within one does not automatically establish that everything is normal.

Laboratories may use different reference intervals or units, so the number is meaningful only alongside the range and units reported for that test. Interpretation can also depend on which sex-specific interval applies. The result is described as higher being better within the reference framework, but that direction alone does not determine what an individual result means.

A single Anti-Müllerian Hormone value is not a diagnosis. Results outside the report’s reference range should be discussed with a clinician, who can interpret them in the context of the person, the test, and any relevant medical information.

Interventions have been evaluated in trials that measured Anti-Müllerian Hormone directly, so these findings are more relevant to this marker than evidence based only on related outcomes.

Inositol has shown conflicting movement: direct findings point in opposing directions, so its effect on Anti-Müllerian Hormone cannot be summarized as consistently increasing or decreasing it. Yoga has been associated with increased Anti-Müllerian Hormone in direct research, although the findings were not uniformly positive.

These results describe movement in a measured biomarker rather than establishing what any individual result means or what action should be taken. Interpretation can depend on the clinical context, and people considering changes related to a medical condition can discuss the relevance of these findings with a clinician.